Nasdepi

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameNasdepi
Drug Alias NameBBP-01
ClassificationSmall molecules
Mechanisms of ActionAdrenergic receptors agonists
TargetsAdrenergic receptors
Therapy Area/IndicationsHypersensitivity, Immediate
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSelect Specialty Hospital—Belhaven Llc
China Registration ClassN/A

Develop Information

Active CompaniesSelect Specialty Hospital—Belhaven Llc
Inactive CompaniesN/A
Active IndicationsHypersensitivity, Immediate
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A